On 2025-05-06, Aligos Therapeutics, Inc. (ALGS) announced earnings per share of $-2.11 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-2.80.
The next expected annoucement date for quarterly earnings is 2025-08-05, with an average estimated earnings per share of $-2.35 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-06 | 2025-03-31 | $-2.80 | $-2.11 |
| 2025-03-10 | 2024-12-31 | $-1.91 | $-3.41 |
| 2024-11-06 | 2024-09-30 | $-2.15 | $-3.07 |
| 2024-08-06 | 2024-06-30 | $-4.00 | $0.75 |
| 2024-05-07 | 2024-03-31 | $-4.75 | $-5.50 |
| 2024-03-12 | 2023-12-31 | $-6.75 | $-5.50 |
| 2023-11-02 | 2023-09-30 | $-12.00 | $-10.25 |
| 2023-08-03 | 2023-06-30 | $-12.50 | $-10.75 |
| 2023-05-04 | 2023-03-31 | $-12.25 | $-13.25 |
| 2023-03-09 | 2022-12-31 | $-12.25 | $-12.75 |
| 2022-11-02 | 2022-09-30 | $-14.25 | $-11.00 |
| 2022-08-04 | 2022-06-30 | $-16.25 | $-11.75 |
| 2022-05-04 | 2022-03-31 | $-16.50 | $-21.00 |
| 2022-03-10 | 2021-12-31 | $-20.75 | $-22.25 |
| 2021-11-04 | 2021-09-30 | $-20.75 | $-19.50 |
| 2021-08-05 | 2021-06-30 | $-20.25 | $-19.75 |
| 2021-05-10 | 2021-03-31 | $-22.50 | $-18.50 |
| 2021-03-23 | 2020-12-31 | $-22.50 | $-27.25 |